Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fc Global Realty Inc (FCRE)

Fc Global Realty Inc (FCRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 38,871
  • Shares Outstanding, K 389,104
  • Annual Sales, $ 40 K
  • Annual Income, $ -2,040 K
  • 60-Month Beta 2.31
  • Price/Sales 1,802.22
  • Price/Cash Flow N/A
  • Price/Book 0.69
Trade FCRE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 11/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0450 +122.00%
on 10/15/19
0.2189 -54.36%
on 10/29/19
-0.0990 (-49.77%)
since 10/11/19
3-Month
0.0302 +230.79%
on 10/03/19
0.3100 -67.77%
on 08/16/19
-0.1501 (-60.04%)
since 08/09/19
52-Week
0.0301 +231.89%
on 02/06/19
0.5600 -82.16%
on 04/02/19
-0.1456 (-59.31%)
since 11/09/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Photomedex, Inc. develops, manufactures and markets therapeutic excimer laser-based instrumentation designed to treat psoriasis and vitiligo. They are also developing their technology for the treatment of other skin disorders. They've received the first Food and Drug Administration, or FDA, approval...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.1266
1st Resistance Point 0.1132
Last Price 0.0999
1st Support Level 0.0733
2nd Support Level 0.0468
3rd Support Level N/A

See More

52-Week High 0.5600
Fibonacci 61.8% 0.3576
Fibonacci 50% 0.2950
Fibonacci 38.2% 0.2325
Last Price 0.0999
52-Week Low 0.0301

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar